Evidence map›Paper›PMID 37997654›Full record

ArticleEpidemiology and infection2023

Evaluation of a combined detection of SARS-CoV-2 and its variants using real-time allele-specific PCR strategy: an advantage for clinical practice.

Lucía Chaves-Blanco, Adolfo de Salazar, Ana Fuentes, Laura Viñuela, Javier Perez-Florido, Joaquín Dopazo, Federico García

Abstract read
In one paragraph

Article in Epidemiology and infection, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lucía Chaves-BlancoServicio de Microbiología, Hospital Universitario Clínico San Cecilio, Granada, Spain.
Adolfo de SalazarServicio de Microbiología, Hospital Universitario Clínico San Cecilio, Granada, Spain.
Ana FuentesServicio de Microbiología, Hospital Universitario Clínico San Cecilio, Granada, Spain.
Laura ViñuelaServicio de Microbiología, Hospital Universitario Clínico San Cecilio, Granada, Spain.
Javier Perez-FloridoComputational Medicine Platform, Andalusian Public Foundation Progress and Health-FPS, Sevilla, Spain.
Joaquín DopazoComputational Medicine Platform, Andalusian Public Foundation Progress and Health-FPS, Sevilla, Spain.
Federico GarcíaServicio de Microbiología, Hospital Universitario Clínico San Cecilio, Granada, Spain.ORCID 0000-0001-7611-781X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to assess the ability of a real-time reverse transcription polymerase chain reaction (RT-PCR) with multiple targets to detect SARS-CoV-2 and its variants in a single test. Nasopharyngeal specimens were collected from patients in Granada, Spain, between January 2021 and December 2022. Five allele-specific RT-PCR kits were used sequentially, with each kit designed to detect a predominant variant at the time. When the Alpha variant was dominant, the kit included the HV69/70 deletion, E and N genes. When Delta replaced Alpha, the kit incorporated the L452R mutation in addition to E and N genes. When Omicron became dominant, L452R was replaced with the N679K mutation. Before incorporating each variant kit, a comparative analysis was carried out with SARS-CoV-2 whole genome sequencing (WGS). The results demonstrated that RT-PCR with multiple targets can provide rapid and effective detection of SARS-CoV-2 and its variants in a single test. A very high degree of agreement (96.2%) was obtained between the comparison of RT-PCR and WGS. Allele-specific RT-PCR assays make it easier to implement epidemiological surveillance systems for effective public health decision making.

Indexed as

COVID-19SARS-CoV-2AllelesCOVID-19 TestingHumansReal-Time Polymerase Chain ReactionSensitivity and Specificityreal-time allele-specificSARS-CoV-2surveillance

Identifiers

PMID37997654
PMCPMC10753446

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.